Efficacy and Safety of Addition of Anti-PD1 to Chemotherapy in Treatment of Non-Small Cell Lung Cancer.
Ru, Chu-Hui
Efficacy and Safety of Addition of Anti-PD1 to Chemotherapy in Treatment of Non-Small Cell Lung Cancer. [electronic resource] - Combinatorial chemistry & high throughput screening 2018 - 711-717 p. digital
Publication Type: Journal Article; Meta-Analysis; Review
1875-5402
10.2174/1386207322666190125150921 doi
Antineoplastic Agents--pharmacology
Biomarkers, Tumor--analysis
Carcinoma, Non-Small-Cell Lung--diagnosis
Docetaxel--pharmacology
Humans
Lung Neoplasms--diagnosis
Programmed Cell Death 1 Receptor--analysis
Efficacy and Safety of Addition of Anti-PD1 to Chemotherapy in Treatment of Non-Small Cell Lung Cancer. [electronic resource] - Combinatorial chemistry & high throughput screening 2018 - 711-717 p. digital
Publication Type: Journal Article; Meta-Analysis; Review
1875-5402
10.2174/1386207322666190125150921 doi
Antineoplastic Agents--pharmacology
Biomarkers, Tumor--analysis
Carcinoma, Non-Small-Cell Lung--diagnosis
Docetaxel--pharmacology
Humans
Lung Neoplasms--diagnosis
Programmed Cell Death 1 Receptor--analysis